SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-010484
Filing Date
2022-06-30
Accepted
2022-06-30 16:24:41
Documents
12
Period of Report
2022-06-24
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cydy-20220624x8k.htm   iXBRL 8-K 66748
  Complete submission text file 0001558370-22-010484.txt   181393

Data Files

Seq Description Document Type Size
2 EX-101.SCH cydy-20220624.xsd EX-101.SCH 3054
3 EX-101.LAB cydy-20220624_lab.xml EX-101.LAB 14197
4 EX-101.PRE cydy-20220624_pre.xml EX-101.PRE 9296
6 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20220624x8k_htm.xml XML 4305
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-49908 | Film No.: 221058323
SIC: 2834 Pharmaceutical Preparations